LONDON, October 19 /PRNewswire/ -- The Lancet(R), the world’s longest continuously published medical journal, has reached a milestone - the number of registered users of its website, http://www.thelancet.com/, has now surpassed the ‘One Million Mark’.
In 1996, The Lancet became the world’s first medical journal to offer full-text online access to research articles. Usage of http://www.thelancet.com/ has continued to grow dramatically as more people turn to online information sources. At a time when the methods by which medical research is communicated to the world have once again become a ‘hot issue’, this is a singularly significant achievement for The Lancet.
David Allen, Head of Circulation for The Lancet said: “Pioneering researchers look to a ground-breaking journal like The Lancet to communicate their work to the greatest possible number of users - whether practitioners or fellow members of the medical research community. The Lancet is committed to delivering more peer-reviewed research to more end-users via more channels than ever before.”
Downloads of The Lancet content by institutional users via ScienceDirect(R) (Elsevier’s electronic platform) topped 2.4 million in 2003 alone. The number of registered users of our website, http://www.thelancet.com/, continues to rise and this summer saw the launch of The Lancet Mobile - offering The Lancet content via mobile phone and personal digital assistant for the first time.”
The Lancet, as well as more than 600 Elsevier journals, continues to support the World Health Organization’s Health InterNetwork Access to Research Initiative (HINARI), thereby making its content freely available through the internet to users in the developing world.
About The Lancet
Founded in 1823 by surgeon Thomas Wakley with a vision ‘to inform, to reform, and to entertain’, nearly 200 years later The Lancet’s vision remains unchanged. The journal is one of a select few weekly medical titles published worldwide which seeks to influence clinical practice by the publication of high-quality peer-reviewed research covering a broad spectrum of medical disciplines of appeal to clinical practitioners and research academics alike.
In addition to the publication of peer-reviewed research, the journal educates readers through a weekly seminar on a specific topic and regular review articles analysing the status of research in a particular field; regular obituaries and reviews of books, websites, and exhibitions and a lively correspondence section add to The Lancet’s vibrancy and colour. Available by print or online subscription, recent developments have seen the emergence of three monthly specialty review journals: The Lancet Oncology, The Lancet Infectious Diseases, and The Lancet Neurology. October 2003 heralded the arrival of 180 years of electronic Lancet archive material from ScienceDirect(R).
About Elsevier Elsevier is a world-leading publisher of scientific, technical and medical information products and services, which includes The Lancet. Working in partnership with the global science and health communities, Elsevier’s 6,800 employees in 86 offices worldwide publish more than 1,800 journals and 2,200 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.news.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier’s ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
CONTACT: Marike Westra, Tel: +31-20-485-2736 Marike.Westra@elsevier.com